Biotech & pharma
Daily pill for Duchenne muscular dystrophy
22 Jun 2011
Lab-grown meat would 'cut emissions and save energy'
21 Jun 2011
Meat grown using tissue engineering techniques, so-called ‘cultured meat’, would generate up to 96% lower greenhouse gas emissions than conventionally produced meat, according to a new study
Nanoparticles disguised as red blood cells to deliver cancer-fighting drugs
By By Catherine Hockmuth | 21 Jun 2011
The method involves collecting the membrane from a red blood cell and wrapping it like a powerful camouflaging cloak around a biodegradable polymer nanoparticle stuffed with a cocktail of small molecule drugs
Swarming nanoparticles communicate to boost drug concentrations near tumours
By By Susan Brown | 21 Jun 2011
New breakthrough in high blood pressure research
17 Jun 2011
TRC researchers isolate new molecule to fight TB
16 Jun 2011
Why we are so complicated
16 Jun 2011
The complex web of protein interactions in our cells may be masking an ever-worsening problem.
"Chemobath" for colon cancer undergoes evaluation
By By Jackie Carr | 11 Jun 2011
Trapping deadly human viruses using decoys
08 Jun 2011
Major breakthrough in shrimp research at Andhra Pradesh
07 Jun 2011
The technology involves sex reversal of scampi males into functional females through microsurgical intervention and mating them with normal males to produce all-male progeny
Neutrons provide first sub-nanoscale snapshots of Huntington's disease protein
By By Agatha Bardoel | 06 Jun 2011
Advances in chemical synthesis reveal rare natural product with potent pain-killing properties
03 Jun 2011
Potential new drug candidate found for Alzheimer's disease
By By Debra Kain | 01 Jun 2011
Pancreas betrayed by 'double agent'
30 May 2011
How shifts in temperature primes immune response
By By Laura Bonetta | 28 May 2011
Latest articles
Featured articles
The decoupling paradox: Why Wall Street keeps funding AI despite $100 oil
By Axel Miller | 11 May 2026
AI infrastructure stocks continue rallying despite $100 oil as investors bet on productivity gains and semiconductor demand in 2026.
Hybrid bonding gains attention as AI chip packaging demand grows
By Cygnus | 23 Apr 2026
Hybrid bonding is driving AI chip packaging demand as backend technologies gain importance in the semiconductor supply chain.
The agentic transition: how enterprises are scaling AI from pilot to profit
By Cygnus | 22 Apr 2026
AI has entered its execution era. Discover how companies like Valeo and Microsoft are scaling agentic AI systems—from copilots to autonomous workflows driving real business impact.
Post-splashdown: What Artemis II taught us about the ‘deep space wall’
By Axel Miller | 15 Apr 2026
Artemis II splashdown marks a breakthrough in deep space exploration. Discover AVATAR radiation data, Orion’s distance record, and insights shaping NASA’s 2028 Moon mission.
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
